Prevalence and factors related with the presence of albuminuria and its stages in patients with type 1 diabetes mellitus

被引:9
作者
Chillaron, Juan J. [1 ]
Flores-Le-Roux, Juana A. [1 ]
Sales, Maria R. [2 ]
Puig-de-Dou, Jaume [3 ]
Castells, Ignasi [4 ]
Benaiges, David [1 ]
Pedro-Botet, Juan [1 ]
机构
[1] Univ Autonoma Barcelona, Serv Endocrinol & Nutr, Hosp del Mar, IMIM Inst Hosp del Mar Invest Med, Barcelona 08003, Spain
[2] Consorci Sanit Parc Tauli, Med Interna Serv, Barcelona, Spain
[3] Hosp del Mar, Serv Endocrinol & Nutr, Barcelona, Spain
[4] Hosp Granollers, Serv Endocrinol & Nutr, Barcelona, Spain
来源
NEFROLOGIA | 2013年 / 33卷 / 02期
关键词
Type; 1; diabetes; Chronic complications; Metabolic control; Epidemiology; Nephropathy; METABOLIC SYNDROME; COMPLICATIONS; MORTALITY; NEPHROPATHY; ASSOCIATION; POPULATION; DISEASE;
D O I
10.3265/Nefrologia.pre2012.Oct.11643
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Despite the beneficial effects of intensive insulin therapy, nephropathy continues to be a major concern in type 1 diabetes mellitus (DM). Given the scarce data on this subject in our population, we performed an observational study in order to analyze the prevalence of albuminuria and its stages in a series of patients with type 1 DM and to evaluate the related factors. Patients and methods: Cross-sectional study that included all patients aged 18 and over, diagnosed of type 1 DM for at least 6 months, consecutively attended during 2008 at the Hospital del Mar de Barcelona and Hospital Granollers. Results: 291 patients were analyzed and 46 (20.2%) had micro- or macroalbuminuria. Albuminuric patients, compared to those without were older (42.0 +/- 12.3 years vs 37.1 +/- 11.5 years), had longer duration of diabetes (22.5 +/- 11.5 years vs 14.1 +/- 10.1 years), and higher body mass index (26.3 +/- 3.7kg/m(2) vs 25.2 +/- 3.4kg/m(2)), glycosylated hemoglobin (8.15 +/- 1.5% vs 7.59 +/- 1.4%) and systolic blood pressure (139.7 +/- 21.7mmHg vs 122.2 +/- 20.3mmHg). Multivariate analysis showed an independent association of albuminuria with diabetes duration (OR 1.081, 95% CI 1.038-1.126), triglyceride levels (OR 1.011, 95% CI: 1.002-1.018), smoking habit (OR 3.279, CI 95%: 1.114-9.654) and hypertension (OR 3.495, 95% CI: 1.074-11.368). Conclusion: In our series, one out of five patients with type 1 DM had micro- or macroalbuminuria, and its presence is associated with diabetes duration, triglyceride concentration, smoking and hypertension.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 16 条
  • [1] Standards of Medical Care in Diabetes-2009
    不详
    [J]. DIABETES CARE, 2009, 32 : S13 - S61
  • [2] [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004]
  • [3] Cantón A, 2004, MED SCI MONITOR, V10, pCR185
  • [4] Estimated Glucose Disposal Rate in Assessment of the Metabolic Syndrome and Microvascular Complications in Patients with Type 1 Diabetes
    Chillaron, Juan J.
    Goday, Alberto
    Flores-Le-Roux, Juana A.
    Benaiges, David
    Carrera, Maria J.
    Puig, Jaume
    Cano-Perez, Juan F.
    Pedro-Botet, Juan
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09) : 3530 - 3534
  • [5] Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes
    de Boer, Ian H.
    Sun, Wanjie
    Cleary, Patricia A.
    Lachin, John M.
    Molitch, Mark E.
    Steffes, Michael W.
    Zinman, Bernard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (25) : 2366 - 2376
  • [6] Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and Microalbuminuria An Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort
    de Boer, Ian H.
    Rue, Tessa C.
    Cleary, Patricia A.
    Lachin, John M.
    Molitch, Mark E.
    Steffes, Michael W.
    Sun, Wanjie
    Zinman, Bernard
    Brunzell, John D.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (05) : 412 - 420
  • [7] THE PITTSBURGH INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) MORBIDITY AND MORTALITY STUDY - MORTALITY RESULTS
    DORMAN, JS
    LAPORTE, RE
    KULLER, LH
    CRUICKSHANKS, KJ
    ORCHARD, TJ
    WAGENER, DK
    BECKER, DJ
    CAVENDER, DE
    DRASH, AL
    [J]. DIABETES, 1984, 33 (03) : 271 - 276
  • [8] Incidence of end-stage renal disease in patients with type 1 diabetes
    Finne, P
    Reunanen, A
    Stenman, S
    Groop, PH
    Grönhagen-Riska, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (14): : 1782 - 1787
  • [9] The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
    Groop, Per-Henrik
    Thomas, Merlin C.
    Moran, John L.
    Waden, Johan
    Thorn, Lena M.
    Makinen, Ville-Petteri
    Rosengard-Barlund, Milla
    Saraheimo, Markku
    Hietala, Kustaa
    Heikkila, Outi
    Forsblom, Carol
    [J]. DIABETES, 2009, 58 (07) : 1651 - 1658
  • [10] The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus
    Laing, SP
    Swerdlow, AJ
    Slater, SD
    Botha, JL
    Burden, AC
    Waugh, NR
    Smith, AWM
    Hill, RD
    Bingley, PJ
    Patterson, CC
    Qiao, Z
    Keen, H
    [J]. DIABETIC MEDICINE, 1999, 16 (06) : 466 - 471